Frans Gorus

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text

Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

Julián Aragonés, Martin Schneider, Katie Van Geyte et al. · Nature Genetics · 2008 · 475 citations · Full text

Biochemistry, Redox Regulator, Physiology +9

Cardiac Troponins I and T Are Biological Markers of Left Ventricular Dysfunction in Septic Shock

Kristien M. ver Elst, Herbert Spapen, Duc Nam Nguyen et al. · Clinical Chemistry · 2000 · 323 citations

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

Bart Keymeulen, Melanie Walter, Chantal Mathieu et al. · Diabetologia · 2010 · 310 citations · Full text

Obesity, Metabolic Syndrome, Diabetes Management +12

Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient

Daniel Jacobs‐Tulleneers‐Thevissen, Marie Chintinne, Z. Ling et al. · Diabetologia · 2013 · 226 citations · Full text

Regenerative Medicine, Tissue Engineering, Type 1 +11